REQUEST A DEMO
Total
USD $0.00
Search more companies

Plus Solinea Pharma Sp. z o.o. (Poland)

Main Activities: Other Personal and Household Goods Repair and Maintenance
Full name: Plus Solinea Pharma Sp. z o.o. Profile Updated: March 15, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Plus Solinea Pharma Sp. z o.o. is an enterprise based in Poland. Its main office is in Elizowka. It operates in the Other Personal and Household Goods Repair and Maintenance sector. It was first established on August 20, 2018. From the latest financial highlights, Plus Solinea Pharma Sp. z o.o. reported a net sales revenue increase of 13.14% in 2024. Its total assets grew by 68.49% over the same period. The net profit margin of Plus Solinea Pharma Sp. z o.o. increased by 1.62% in 2024.

Headquarters
Ul. Szafranowa 6
Elizowka; Lubelskie; Postal Code: 21-003

Contact Details: Purchase the Plus Solinea Pharma Sp. z o.o. report to view the information.

Basic Information
Registered Capital:
Purchase the Plus Solinea Pharma Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Plus Solinea Pharma Sp. z o.o. report to view the information.
Incorporation Date:
August 20, 2018
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Plus Solinea Pharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
13.14%
Total operating revenue
12.94%
Operating profit (EBIT)
151.66%
EBITDA
151.66%
Net Profit (Loss) for the Period
151.66%
Total assets
68.49%
Total equity
90.85%
Operating Profit Margin (ROS)
1.62%
Net Profit Margin
1.62%
Return on Equity (ROE)
-627.03%
Quick Ratio
0.26%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?